Author:
Maguire Melissa,Ben-Menachem Elinor,Patten Anna,Malhotra Manoj,Ngo Leock Y.
Subject
Behavioral Neuroscience,Neurology (clinical),Neurology
Reference42 articles.
1. Perampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy;Hanada;Epilepsia,2011
2. European Medicines Agency (EMA). FYCOMPA® Annex I: Summary of Product Characteristics, January 2021. Available at: https://www.ema.europa.eu/en/documents/product-information/fycompa-epar-product-information_en.pdf. Accessed November 8, 2021.
3. Food and Drug Administration (FDA). FYCOMPA® Prescribing Information, February 2021. Available at: https://www.fycompa.com/-/media/Files/Fycompa/Fycompa_Prescribing_Information.pdf. Accessed November 8, 2021.
4. Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304;French;Neurology,2012
5. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305;French;Epilepsia,2013
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献